skip to content »

Dating with terminal disease

dating with terminal disease-21

A 2007 American study in mice seemed to show that curcumin helped to stop the spread of breast cancer cells to other parts of the body.Doctors think that curcumin stays in the digestive system and is absorbed by the cells in the bowel.

dating with terminal disease-74dating with terminal disease-16dating with terminal disease-13dating with terminal disease-90

The ability of curcumin to regulate a variety of signaling pathways involved in cell growth, apoptosis, invasion, metastasis, and angiogenesis in preclinical studies elicited scientific interest in its potential as an anticancer agent in tumor therapy.It has the best effects on breast cancer, bowel cancer, stomach cancer and skin cancer cells.A 2007 American study that combined curcumin with chemotherapy to treat bowel cancer cells in a laboratory showed that the combined treatment killed more cancer cells than the chemotherapy alone.Scientists discovered that turmeric is effective in killing cancer cells and also preventing their growth.According to the American Cancer Society, tests indicate that curcumin "interferes with several important molecular pathways involved in cancer development, growth and spread" and has boosted the effects of chemotherapy in animals.The root and rhizome stem of the Curcuma longa plant is crushed and powdered into ground Turmeric spice.

Ground Turmeric is used worldwide as a seasoning and is the source of extracted Curcumin.

Over the years, cancer research has examined the role curcumin plays in treating this disease.

A number of laboratory studies on cancer cells have shown that curcumin does have anticancer effects.

Curcumin is one of the most powerful and promising chemopreventive and anticancer agents, and epidemiological evidence demonstrates that people who incorporate high doses of this spice in their diets have a lower incidence of cancer.

Curcumin's epigenetic modulation has been studied by the US National Cancer Institute (NCI) and academic investigators around the world.

Because of low toxicity and great efficacy in multiple in vitro and in vivo cancer models, Curcumin was selected for further development, put through extensive toxicology testing and has successively made it through the first stages (Phase I) of clinical testing abroad and is currently in clinical trials at several sites in the U. A phase I clinical trial looked at giving curcumin to 25 patients with pre cancerous changes in different organs. Anderson Cancer Center in Houston, TX state that Curcumin has enormous potential to prevent and treat cancer.